Related Experiment Video
Updated: Jun 5, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Improving the measurement of self-reported medication nonadherence
Corrine I Voils1, Rick H Hoyle, Carolyn T Thorpe
1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA. voils001@mc.duke.edu
Journal of Clinical Epidemiology
|January 4, 2011
Summary
Improving medication nonadherence measurement requires distinguishing between reasons for nonadherence and the extent of nonadherence. Longitudinal assessment reveals whether nonadherence is transient or stable, enhancing chronic disease management.
Area of Science:
- Clinical Measurement
- Health Psychology
- Chronic Disease Management
Background:
- Medication nonadherence is a critical challenge in managing chronic diseases, impacting treatment efficacy.
- Current self-report measures for medication nonadherence suffer from poor reliability and distributional characteristics.
- Existing measurement tools often conflate indicators of nonadherence causes and effects, limiting their utility.
Purpose of the Study:
- To identify fundamental measurement issues limiting self-reported medication nonadherence assessment.
- To propose recommendations for enhancing the accuracy and reliability of nonadherence measurement.
- To improve the understanding of medication-taking behavior in chronic conditions like hypertension.
Main Methods:
- Reviewed self-report medication nonadherence measures, focusing on hypertension management.
- Evaluated measures based on the conflation of causal and effect indicators.
- Assessed the lack of evidence regarding the temporal stability of nonadherence.
Main Results:
- Distinguishing between effect indicators (extent of nonadherence) and causal indicators (reasons for nonadherence) improves measurement.
- Longitudinal assessment is crucial for understanding the transient versus stable nature of nonadherence.
- Statistical modeling can illuminate the stability of medication nonadherence over time.
Conclusions:
- Addressing these measurement issues can significantly enhance self-reported nonadherence assessment.
- Improved measurement allows for more accurate conclusions about medication adherence behaviors.
- Enhanced assessment can inform the development of more effective interventions for medication nonadherence.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:30Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...